Sign in

CIK 0001906324

  • Large accelerated filer

QuidelOrtho Corp

Sign in to watch
Ticker
QDEL
Exchange
Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Jan 1
Entity type
Operating
EIN
874496285
Phone
+1 858-552-1100
Business address
9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
Former names
Coronado Topco, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-11 Bujarski Robert Joseph EVP & COO Grant or award +824 36,546
2023-02-11 Bujarski Robert Joseph EVP & COO Shares withheld for taxes −434 $86.50 $38K 36,112
2023-02-11 Bujarski Robert Joseph EVP & COO Exercise or conversion · Restricted Stock Units (Converted) −2,749 0
2023-02-11 Bujarski Robert Joseph EVP & COO Exercise or conversion · Restricted Stock Units (Premium) −824 0
2023-02-11 BRYANT DOUGLAS C President & CEO Grant or award +7,309 529,238
2023-02-11 BRYANT DOUGLAS C President & CEO Shares withheld for taxes −3,453 $86.50 $299K 525,785
2023-02-11 BRYANT DOUGLAS C President & CEO Grant or award +2,192 527,977
2023-02-11 BRYANT DOUGLAS C President & CEO Shares withheld for taxes −1,087 $86.50 $94K 526,890
2023-02-11 BRYANT DOUGLAS C President & CEO Exercise or conversion · Restricted Stock Units (Converted) −7,309 0
2023-02-11 BRYANT DOUGLAS C President & CEO Exercise or conversion · Restricted Stock Units (Premium) −2,192 0
2023-02-04 Bujarski Robert Joseph EVP & COO Grant or award +3,623 36,259
2023-02-04 Bujarski Robert Joseph EVP & COO Shares withheld for taxes −1,905 $89.70 $171K 34,354
2023-02-04 Bujarski Robert Joseph EVP & COO Exercise or conversion · Restricted Stock Units −3,623 0
2023-02-04 BRYANT DOUGLAS C President & CEO Grant or award +18,720 531,211
2023-02-04 BRYANT DOUGLAS C President & CEO Shares withheld for taxes −9,282 $89.70 $833K 521,929
2023-02-04 BRYANT DOUGLAS C President & CEO Exercise or conversion · Restricted Stock Units −18,720 0
2023-02-04 Kroll Werner SVP, Research & Development Grant or award +3,925 26,190
2023-02-04 Kroll Werner SVP, Research & Development Shares withheld for taxes −1,947 $89.70 $175K 24,243
2023-02-04 Kroll Werner SVP, Research & Development Grant or award +4,268 28,511
2023-02-04 Kroll Werner SVP, Research & Development Shares withheld for taxes −2,117 $89.70 $190K 26,394

Page 38 of 50 · 990 trades